A detailed history of Westmount Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Westmount Partners, LLC holds 5,027 shares of ABT stock, worth $572,625. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,027
Previous 5,059 0.63%
Holding current value
$572,625
Previous $577 Million 1.42%
% of portfolio
0.17%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$111.93 - $119.39 $3,581 - $3,820
-32 Reduced 0.63%
5,027 $569 Million
Q3 2024

Jan 13, 2025

BUY
$100.07 - $118.13 $506,254 - $597,619
5,059 New
5,059 $577 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Westmount Partners, LLC Portfolio

Follow Westmount Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westmount Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westmount Partners, LLC with notifications on news.